None listed
Conditions
Interventions
None listed
Sponsors
department Of Health and Family welfare
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group between 30 to 60 years irrespective of caste, sex, occupation, religion and socio-economic status. 2. Patients who agreed to follow the study protocol and give consent for clinical trial. 3. Patient having IDR Score more than 50 4. Patient with clinical sign and symptoms of prameha as mentioned in classical ayurvedic text- prabhuta mutrata Avilamutrata Pipasadhikya Sithilangata, Khudha dhikyata Karapada daha Swedadhiky Galatalusosh Nidradhikyata Dourbalya 5. Patients having BMI more than 25 kg per meter square 6. patients having Biochemical features Fasting Plasma Glucose 100-125 mg per dl Post Prandial Plasma Glucose 140-199 mg per dl Glycated hemoglobin HbA1c 5.7-6.4
Exclusion criteria
Exclusion criteria: 1. Patients who was currently participating in any other clinical trial. 2. Patients below 30 years and above 60 years. 3. Patients with known diagnosis case of Type-I CVA, Stroke HTN (essential hypertension) 4. Fasting plasma glucose more or equal 126mg per dl 5. Post prandial plasma glucose more or equal 200 mg per dl 6. Glycated hemoglobin (HbA1c) more or equal 6.5 7. Serum urea more 40 mg per dl 8. Serum creatinine more 1.36 mg per dl 9. Patients having BMI less than 25 kg per meter square 10. Patient with known diagnosis case of nephropathy, pancreatitis, cardiac disease. 11. Pregnant and lactating females. 12. Patients suffering from other major illness like CA, PTB, Hepatitis, HIV or any other conditions were considered as unfit for enrolment in the trial. 13. patients having any surgical intervention since last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the role of internal use of Darvadi kasaya and life style modifications in the management of prameha purvarupavastha (Pre-Diabetic State). To assess the changes in the IDR Score and FBS, PPBS, HbA1C, urine RE/ME, urine ACR, serum urea and creatinine, QoL score, BMI between two groups at the end of the trial in patients with prameha purvarupavastha. To assess the complication or adverse effects, if any during the course of the therapTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the role of internal use of darvadi kasaya and lifestyle modification in the management of prameha purvarupavastha (Pre-Diabetic State).Timepoint: 90 days | — |
Countries
India
Contacts
Public ContactDR TAPAS BHADURI
Institute Of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Outcome results
None listed